Applied Nutrition Reports Higher Earnings and Rising Costs
Applied Nutrition, a sports-nutrition company based in the UK, announced on August 26 that its financial results for the fiscal year 2026 would exceed market expectations. The company projects a 40% year-on-year increase in its adjusted EBITDA, totaling approximately £43.3 million. This figure excludes the impact from its June acquisition of the US-based Nutrablend Group's assets.
The company also estimates a 50% increase in revenue to £160 million, surpassing the earlier forecast of £148.4 million. Analysts had predicted an EBITDA of £42 million for the year ending July, but the company's results indicate stronger performance.
Applied Nutrition’s stock price initially rose over 8% to 348.5p in early trading before settling at approximately 323p by 13:34 BST. Despite the positive earnings forecast, the company warns that margins will be strained due to higher whey protein costs, with a slight decline expected in the EBITDA margin for fiscal year 2027.
Looking ahead, the business anticipates a 13% growth in adjusted EBITDA to about £49 million for the year ending July 2027, with projected revenues of £205 million, exceeding market expectations of £186.2 million.
The company's products, sold under brands like ABE, BodyFuel, and Endurance, are available in more than 85 countries, comprising over 120 different items. In June, Applied Nutrition acquired most of Nutrablend Group’s assets for $16 million in cash. This acquisition included Nutrablend's manufacturing and logistics site in Buffalo, New York, and its supplement brands Basic Supplements and GR8 Lifestyle.
Full-year financial results from Applied Nutrition are expected to be released on or around November 16.
